 (CBI) is pleased to announce Preclinical and Clinical Imaging for Drug Development being held February 23, 2011 from 9:30 a.m. - 6:00 p.m. EST. CBI provides an opportunity to bring together a diverse collection of imaging experts from around the world to discuss the latest imaging technologies relevant to today's practitioners in a virtual conference environment. 

This inaugural virtual conference will provide insights and practical information on the latest developments affecting this rapidly evolving field. This conference offers an understanding of the importance of R&D into novel therapies and discusses the application of current and innovative imaging technologies and developments in oncology, CNS and cardiovascular therapeutic areas. This conference will also examine the importance of translational studies and how to bridge the preclinical to clinical divide while emphasizing how to develop and incorporate imaging solutions that lead to earlier diagnosis. 

Confirmed speakers include: 
  

Peter Conti, MD, PhD, Professor of Radiology, Biomedical Engineering and Pharmacy, USC, Los Angeles, CA 

Gregory Goldmacher, MD, PhD, Assistant Director, Medical Affairs, ICON Medical Imaging 

Neeta Fahey, Associate Director, Clinical Imaging and Technologies, Pfizer Inc. 

Zachary H. Levine, Physicist, National Institute of Standards and Technology 

Thomas Bocan, PhD, Senior Director, Head of BioImaging Center, Pharma Therapeutics Research & Development, Pfizer Inc. 

Jacek Capala, PhD, Radiation Oncology Branch, NIH/NCI 

Jasper Lee, Dept. of Biomedical Engineering, University of Southern California 

CBI is a subsidiary of Advanstar Communications Inc., and develops market-driven, unbiased conferences in the fields of pharmaceuticals and biotech, medical devices, and managed care markets. 

 is also owned by Advanstar Communications Inc.